Multiple Myeloma
摘要
18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)-computed tomography imaging assesses the distribution and treatment response of metabolically active disease lesions. PET imaging using several non-FDG radiotracers has been performed in multiple myeloma (MM). This chapter will answer common questions about PET tracers used in MM, their clinical applications, advantages, and limitations.